Inspire Investing’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$524K Sell
24,274
-9,918
-29% -$183K 0.03% 481
2025
Q4
$469K Buy
34,192
+8,561
+33% +$133K 0.04% 424
2025
Q3
$454K Sell
25,631
-260
-1% -$4.11K 0.04% 584
2025
Q2
$391K Buy
25,891
+4,267
+20% +$70.8K 0.04% 484
2025
Q1
$348K Sell
21,624
-1,133
-5% -$21.1K 0.04% 358
2024
Q4
$396K Buy
22,757
+58
+0.3% +$1.02K 0.04% 739
2024
Q3
$398K Sell
22,699
-9,934
-30% -$169K 0.04% 750
2024
Q2
$365K Sell
32,633
-8,725
-21% -$82.2K 0.04% 357
2024
Q1
$360K Buy
41,358
+10,039
+32% +$92.3K 0.04% 475
2023
Q4
$383K Buy
+31,319
New +$217K 0.04% 606

Other funds holding PLSE

Inspire Investing's PLSE Position: Q1 2026 in Review

Inspire Investing reduced its Pulse Biosciences (PLSE) stake by 29% in Q1 2026, selling an estimated $183K and leaving 24,274 shares worth $524K. The position accounts for 0.03% of the portfolio, ranked #481.

Inspire Investing first reported a position in PLSE in Q4 2023 and has held it in 10 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Inspire Investing held 24,274 shares of Pulse Biosciences worth $524K as of Q1 2026.
  • Inspire Investing sold 9,918 Pulse Biosciences shares in Q1 2026, an estimated $183K.
  • Pulse Biosciences made up 0.03% of Inspire Investing's portfolio in Q1 2026, its #481 holding.
  • Inspire Investing first reported a position in Pulse Biosciences in Q4 2023 and has held it in 10 quarters since.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.